Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/19088
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFeig, C-
dc.contributor.authorCheung, KL-
dc.contributor.authorHiligsmann, M-
dc.contributor.authorEvers, SMAA-
dc.contributor.authorSimon, J-
dc.contributor.authorMayer, S-
dc.date.accessioned2019-09-09T10:17:01Z-
dc.date.available2017-09-08-
dc.date.available2019-09-09T10:17:01Z-
dc.date.issued2017-09-08-
dc.identifier.citationExpert Review of Pharmacoeconomics and Outcomes Research, 2017, 18 (2), pp. 223 - 232en_US
dc.identifier.issn1473-7167-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/19088-
dc.format.extent223 - 232-
dc.language.isoenen_US
dc.publisherTaylor & Francisen_US
dc.rightsThis is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Pharmacoeconomics and Outcomes Research on 08 September 2017, available online: http://www.tandfonline.com/10.1080/14737167.2017.1375407-
dc.subjecthealth technology assessmenten_US
dc.subjectbarriersen_US
dc.subjectfacilitatorsen_US
dc.subjectbest-worst scalingen_US
dc.subjectdecision-makingen_US
dc.subjectstakeholdersen_US
dc.titleBest-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austriaen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1080/14737167.2017.1375407-
dc.relation.isPartOfExpert Review of Pharmacoeconomics and Outcomes Research-
pubs.issue2-
pubs.publication-statusPublished-
pubs.volume18-
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf658.36 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.